JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)

CNY 9.85

(0.92%)

Net Debt Summary of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest annual net debt in 2023 was 81.56 Million CNY , down -10.25% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest quarterly net debt in 2024 Q2 was 57.62 Million CNY , down -62.99% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported annual net debt of 90.88 Million CNY in 2022, down -57.93% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported annual net debt of 216.05 Million CNY in 2021, down -64.96% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported quarterly net debt of 57.62 Million CNY for 2024 Q2, down -62.99% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported quarterly net debt of 304.43 Million CNY for 2024 Q3, up 452.2% from previous quarter.

Annual Net Debt Chart of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Historical Annual Net Debt of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Year Net Debt Net Debt Growth
2023 81.56 Million CNY -10.25%
2022 90.88 Million CNY -57.93%
2021 216.05 Million CNY -64.96%
2020 616.51 Million CNY 60.26%
2019 384.69 Million CNY 7.2%
2018 358.84 Million CNY 625.7%
2017 49.44 Million CNY -84.85%
2016 326.43 Million CNY -67.3%
2015 998.39 Million CNY -19.26%
2014 1.23 Billion CNY 44.65%
2013 854.84 Million CNY -10.52%
2012 955.3 Million CNY -13.99%
2011 1.11 Billion CNY 143.6%
2010 455.94 Million CNY 92.95%
2009 236.29 Million CNY -39.54%
2008 390.8 Million CNY -15.95%
2007 464.96 Million CNY 29.46%
2006 359.14 Million CNY 3.74%
2005 346.19 Million CNY 113.81%
2004 161.91 Million CNY 44.98%
2003 111.68 Million CNY 336.63%
2002 -47.19 Million CNY 74.19%
2001 -182.9 Million CNY -12236.84%
2000 -1.48 Million CNY 97.76%
1999 -66.13 Million CNY -163.48%
1998 104.16 Million CNY 246.3%
1997 30.08 Million CNY 21.82%
1996 24.69 Million CNY 0.0%

Peer Net Debt Comparison of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Name Net Debt Net Debt Difference
Beijing Tiantan Biological Products Co., Ltd. -2.68 Billion CNY 103.037%
Jinyu Bio-technology Co., Ltd. -1.7 Billion CNY 104.776%
Vcanbio Cell & Gene Engineering Corp., Ltd -1.46 Billion CNY 105.566%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 2.97 Billion CNY 97.263%
Zhejiang Ausun Pharmaceutical Co., Ltd. -711.3 Million CNY 111.467%
DaShenLin Pharmaceutical Group Co., Ltd. 6.25 Billion CNY 98.696%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. -3.41 Billion CNY 102.385%
GuiZhou SanLi Pharmaceutical Co.,Ltd 38.58 Million CNY -111.384%
Pulike Biological Engineering, Inc. -315.16 Million CNY 125.88%
Beijing Konruns Pharmaceutical Co.,Ltd. -80.42 Million CNY 201.422%
Shanghai Hile Bio-Technology Co., Ltd. -89.9 Million CNY 190.722%
Qingdao Vland Biotech INC. 494.24 Million CNY 83.497%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. -755.56 Million CNY 110.795%
Aurisco Pharmaceutical Co.,Ltd. -428.95 Million CNY 119.015%
Zhejiang East Asia Pharmaceutical Co., Ltd. -4.19 Million CNY 2042.951%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 758.92 Million CNY 89.252%
Mabwell (Shanghai) Bioscience Co., Ltd. -358.25 Million CNY 122.768%
Beijing Hotgen Biotech Co., Ltd. -257.13 Million CNY 131.721%
Assure Tech (Hangzhou) Co., Ltd. -321.77 Million CNY 125.349%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 260.4 Million CNY 68.677%
Cabio Biotech (Wuhan) Co., Ltd. -226.91 Million CNY 135.946%
Shanghai Shen Lian Biomedical Corporation -43.72 Million CNY 286.544%
Nanjing Vazyme Biotech Co., Ltd. -679.87 Million CNY 111.997%
Shandong Kexing Bioproducts Co,.Ltd 547.26 Million CNY 85.096%
Shanghai Junshi Biosciences Co., Ltd. -2 Billion CNY 104.074%
Shanghai Model Organisms Center, Inc. -2.84 Million CNY 2964.91%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. -1.22 Billion CNY 106.668%
Xiamen Amoytop Biotech Co., Ltd. -405.03 Million CNY 120.138%
Novogene Co., Ltd. -662.54 Million CNY 112.311%
Shanghai ZJ Bio-Tech Co., Ltd. -2.76 Billion CNY 102.953%
Chengdu Olymvax Biopharmaceuticals Inc. -124.46 Million CNY 165.533%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd -883.23 Million CNY 109.235%
Shanghai Haohai Biological Technology Co., Ltd. -2.33 Billion CNY 103.498%
Jiangsu Bioperfectus Technologies Co., Ltd. -1.59 Billion CNY 105.111%
Jiangsu Aidea Pharmaceutical Co., Ltd. 186.94 Million CNY 56.369%
Chengdu Easton Biopharmaceuticals Co., Ltd. -557.74 Million CNY 114.624%
Sinocelltech Group Limited 2.45 Billion CNY 96.674%
Wuhan Keqian Biology Co.,Ltd -288.23 Million CNY 128.299%
Shanghai Allist Pharmaceuticals Co., Ltd. -1.86 Billion CNY 104.385%
Anhui Huaheng Biotechnology Co., Ltd. 893.66 Million CNY 90.873%
Youcare Pharmaceutical Group Co., Ltd. -1.01 Billion CNY 108.018%
Jiangsu gdk Biotechnology Co., Ltd. -6.38 Million CNY 1377.256%
Beijing Kawin Technology Share-Holding Co., Ltd. -798.7 Million CNY 110.212%
Hangzhou Biotest Biotech Co.,Ltd. -1.9 Billion CNY 104.283%